GENE ONLINE|News &
Opinion
Blog

Pfizer
M&A PfizerSeagen
Pfizer Acquires Seagen for $43 Billion to Capture Leading Position in Oncology
2023-03-14
Trials & Approvals Migraine
Pfizer’s Fast-Acting Migraine Nasal Spray Takes Home US Approval
2023-03-13
Trials & Approvals RSV vaccines
Pfizer and GSK Neck and Neck for First FDA-Approved RSV Vaccine
2023-03-03
Trials & Approvals RSV vaccines
Pfizer’s RSV Vaccine Wins Support From FDA Advisory Panel for Use in Older Adults
2023-03-01
Trials & Approvals Migraine
Pfizer Trumpets Lancet Publication Of Migraine Drug’s Phase 3 Results
2023-02-18
Trials & Approvals Hemophilia B
Pfizer’s Hemophilia B Gene Therapy Meets Phase 3 Endpoints
2022-12-30
Special biopharmam&a
GeneOnline’s Pick: Top 10 M&A Deals in 2022
2022-12-28
Partnerships Diabetes
Pfizer Begins Phase 2 Of Diabetes Drug, Triggering $10 Million Milestone To Sosei Heptares
2022-12-22
Deals Pfizer
Pfizer To Invest $1.26 Billion In Irish Plant, Forms New Vant Company Targeting Inflammation
2022-12-02
COVID-19 COVID-19 Vaccine
Pfizer to Raise COVID-19 Vaccine Prices Amidst Rising Flu Cases
2022-10-24
Pfizer Opts In On Neurological Target In Voyager Deal, Leaving $290 Million In Milestones
2022-10-05
Trials & Approvals Hemophilia A
Pfizer, Sangamo Re-Opens Enrolment For Hemophilia A Gene Therapy
2022-09-26
COVID-19 Pfizer
Pfizer Pledges 6 million COVID-19 Treatment Courses to Global Fund
2022-09-22
Trials & Approvals Pfizer
Pfizer’s Pentavalent Vaccine Shines in Phase 3 Trials Before BLA Submission
2022-09-16
Trials & Approvals Influenza
Pfizer Doses First Patients with an Influenza Vaccine in a Phase 3 Clinical Trial
2022-09-14
1 2 3 4 … 9
LATEST
Pfizer’s Q1 2024 Revenue Declines, Offset by Strong Performance of Non-COVID-19 Products
2024-05-03
Novo Nordisk Revises Outlook: Reports 24% Growth in Q1 2024 Sales, Reaching DKK 65.3 Billion
2024-05-03
UC Riverside Scientists Unveil RNA-based Vaccine Strategy, Potentially Avoiding Endless Booster Shots
2024-05-02
Lilly’s Q1 2024 Financial Report: Full-Year Revenue Outlook Raised by $2 Billion, with a 67% Net Income Increase
2024-05-02
Taiwan Breakthrough: Next-Generation Sequencing Now Covered in Health Insurance, Benefitting 20,000 Cancer Patients Annually
2024-05-02
CellTech Accelerator and Cyto-Facto Inc. Forge Strategic Partnership to Advance CGT Industry Growth
2024-04-29
Kaiser’s Data Breach: 13.4 Million Affected in Healthcare Conglomerates Privacy Crisis
2024-04-26
READ MORE
EVENT
SEE MORE
Newsletter

Subscribe to receive updates.

SIGN UP
Facebook
Youtube
Twitter
Linkedin
About
Explore
More
© 2024 GeneOnline
Privacy Policy | Terms of Service
Privacy Policy | Terms of Service
  • Subscribe to our newsletter and dive into the world of biopharma with us.
SIGN UP
x
Scroll to Top